Takeda

ENTYVIO

Manufacturer:

Takeda

Entyvio HCPCS:

J3380

HCPCS Code Descriptor:

Injection, vedolizumab, 1 mg

Category:

J Code

Entyvio NDCs:

64764-0300-20

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Entyvio:

ENTYVIO is an Immunology drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J3380 is aligned to the drug ENTYVIO.

ACCESS PRICING AND MORE BY REGISTERING

J3380 Added Date:

January 1, 2016

J3380 Effective Date:

January 1, 2016

J3380 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Entyvio billing and coding information.
Entyvio patient assistance information can be found through Takeda Patient Support at the URL: https://www.entyvio.com/?utm_medium=referral&utm_source=Entyvio|Takeda-Pro-Portal
ENTYVIO prescribing information can be found at the link below:
Information regarding ENTYVIO’s side effects can be found at MedlinePlus